Fig 1: Theophylline increases Sox10, Krox20, and P0 expression and eEF1A1 deacetylation.a HDAC2 (12dpl: n = 3, p = 0.025883, 14dpl: n = 5, p = 0.011697), Sox10 (12dpl: n = 3, p = 0.031422, 14dpl: n = 3–4, p = 0.032671), Krox20 (12dpl: n = 3, p = 0.030486, 14dpl and 30dpl: n = 7, p = 0.033493 and 0.022041) and P0 (12dpl: n = 3, p = 0.022239, 14dpl: n = 4-5, p = 0.019084, 30dpl: n = 6, p = 0.0456) Western blots at 12, 14 and 30dpl in lysates of crushed (Cr) or contralateral (Co) sciatic nerves of mice treated at 10dpl with theophylline (Theo) or vehicle (Veh.) for 2 days (12dpl) or 4 days (14 and 30dpl), and quantification normalized to GAPDH and Co. b, c EEF1A1 IP and Ac-eEF1A Western blot (b) and Ac-eEF1A and S100 (SC marker) co-immunofluorescence and DAPI labeling (c) at 12dpl in Cr (c) or in Cr and Co (b) 20 h after one theophylline or vehicle injection, and (b) Ac-eEF1A1 quantification normalized to GAPDH input and Co in theophylline- compared to vehicle-treated groups. N = 3 animals per group (b, c), p = 0.000597 (b). Representative images are shown. d–f GFP (d) and/or Sox10 (d–f) chromatin immunoprecipitation at 12dpl on Krox20 MSE or P0 intron 1 in (d) Cr and fold enrichment normalized to Sox10 input compared to GFP (n = 3 animals, Sox10 and GFP IPs on the same nerve lysate, pKrox20-MSE = 0.032616, pP0-intron-1 = 0.027702) or in Cr (e) collected 20 h after theophylline (Theo) or vehicle (Veh.) treatment or (f) after mocetinostat (Mocet.) or Veh. treatment for 2 days. e N = 5–6 animals per group, pKrox20-MSE = 0.030466, pP0-intron-1 = 0.04003. f N = 3 animals per group, pKrox20-MSE = 0.037396, pP0-intron-1 = 0.023672. g Sox10, P0, HDAC2, and GAPDH Western blots in lysates of P4 DhhCre;Hdac1fl/fl;Hdac2fl/fl dKO and control littermate sciatic nerves treated at P1 with Theo or Veh. for 3 days, and quantification normalized to GAPDH in Theo compared to Veh. N = 6 animals per group, pSox10 = 0.04567, pP0 = 0.033358, pHDAC2 = 0.02891. Dashed lines: samples loaded on the same gel but not on consecutive lanes. Data are presented as mean values ± SEM. Paired (a: HDAC2 and Sox10-12dpl, Krox20-14dpl-30dpl; b, d, e, and f: P0-intron-1; g) or unpaired one-tailed (gray asterisks) or two-tailed (black asterisks) Student’s t-tests. Scale bar: 20 µm (c). Source data are provided as a Source Data file.
Fig 2: EEF1A1 acetylation increases eEF1A1 nuclear localization and decreases Sox10 levels.a GFP Western blot in nuclear (Nucl.) and cytoplasmic (Cyt.) fractions of primary SCs cultured 1 day under de-differentiating conditions and transfected with eEF1A1-GFP, K41Q-GFP, K179Q-GFP or K273Q-GFP and % of protein localized in nucleus or cytoplasm normalized to Lamin A/C and GAPDH (n = 3 independent experiments per group). b–d Sox10 immunofluorescence with GFP fluorescence and DAPI (nuclei) labeling in SCs overexpressing eEF1A1-GFP, K41R-GFP, K179R-GFP or K273R-GFP and cultured under de-differentiating conditions for 3 days, and % of cells with eEF1A1 or mutants localized in cytoplasm only (Cyt. only) or in nucleus and cytoplasm (Nucl. + Cyt., b) or % of low Sox10-expressing cells (c, d). N = 3 independent experiments per group, 18-84 cells counted per group per n. e, f Sox10 immunofluorescence with GFP fluorescence and DAPI (nuclei) labeling in SCs overexpressing eEF1A1-GFP, K41Q-GFP, K179Q-GFP or K273Q-GFP and cultured under proliferating conditions for 2 days, and % of cells with eEF1A1 or mutants localized in cytoplasm only or in nucleus and cytoplasm of SCs (e) or % of low Sox10-expressing cells (f). The lower images are magnifications of the dashed white boxes on the upper images. N = 3 independent experiments per group, 17–71 cells counted per group per n. Arrows show transfected SCs. Orange arrows indicate SCs where eEF1A1 or the mutants are present in the nucleus of SCs. Scale bars: 10 µm (b), 20 µm (e). Data are presented as mean values ± SEM. Unpaired one-tailed (gray asterisks) or two-tailed (black asterisks) Student’s t-tests, p values = 0.029415 (a, K41Q), 0.04884 (a, K179Q), 0.0329 (a, K273Q), 0.023698 (b, K41R), 0.008772 (b, K179R), 0.00946 (b, K273R), 0.189827 (c, K41R), 0.027448 (c, K179R), 0.018314 (c, K273R), 0.405588 (d, K41R), 0.03836 (d, K179R), 0.406686 (d, K273R), 0.011923 (e, K41Q), 0.019373 (e, K179Q), 0.021749 (e, K273Q), 0.009059 (f, K41Q), 0.009399 (f, K179Q), 0.02223 (f, K273Q). Source data are provided as a Source Data file.
Fig 3: Proposed mechanism of Ac-eEF1A1-dependent regulation of Sox10.Schematic representation of mechanisms controlling eEF1A1 acetylation-dependent Sox10 degradation and suggesting deacetylation-dependent remyelination.
Fig 4: Knockdown of eEF1A increases CSFV growth. (A) CSFV genome copies in eEF1A knockdown cells. PK-15 cells transduced with the lenti-sheEF1A or lenti-NC for 24 h were infected with the CSFV Shimen strain at a multiplicity of infection (MOI) of 0.1 for 48 h or 72 h. The CSFV genome copy numbers were assessed using a real-time RT-PCR assay as described previously [25]. (B) CSFV titers in eEF1A-knocked down cells. Virus titers in the supernatant were determined at 48 and 72 h post-infection (hpi) and expressed as 50% tissue culture infective doses (TCID50)/mL. Error bars represent the standard deviations of the means from three independent experiments. p-values were indicated above the bars. (C) Knockdown of eEF1A by lentivirus-mediated shRNAs increased expression of the CSFV Npro protein. The endogenous eEF1A and the CSFV Npro protein were detected by Western blotting using an anti-eEF1A monoclonal antibody (MAb) and an anti-Npro polyclonal antibody (PAb), respectively.
Fig 5: (a) Immunoblotting of native E. histolytica EF1a to test the specificity of the rabbit anti-eEF1a MAb. Lane 1: standard protein molecular weight marker; Lane 2: trophozoite lysates; Lane 3: native EF1a probed by the rabbit anti-eEF1a MAb from trophozoite lysates. (b) Immunoblot for native E. histolytica EF1a to test specificity of polyclonal antibodies. Lane 1: standard protein molecular weight marker; Lane 2: trophozoite lysates; Lane 3: native EF1a probed by the polyclonal antibodies against rEF1a (dilution of 1:4000) from trophozoite lysates.
Supplier Page from Abcam for Anti-eEF1A1/EF-Tu + eEF1A1 + EE1AL3/EEF1A1P5 antibody [EPR9471]